1-(Pyridin-2-yl)piperazine hydrochloride

Catalog No. :
ACROUF948
CAS No. :
129394-11-2
Molecular Formula :
C9H14ClN3
Molecular Weight :
199.68

IUPAC Name:1-(pyridin-2-yl)piperazine hydrochloride

1-(Pyridin-2-yl)piperazine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$65.00Login to see priceInquiryInquiry
5g98%$164.00Login to see priceInquiryInquiry
25g98%$268.00Login to see priceInquiryInquiry
100g98%$346.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(Pyridin-2-yl)piperazine hydrochloride
IUPAC Name1-(pyridin-2-yl)piperazine hydrochloride
Molecular FormulaC9H14ClN3
Molecular Weight199.68
SMILES[H]Cl.N1(C2=NC=CC=C2)CCNCC1
InChI KeyXQVSONPKJXNWJO-UHFFFAOYSA-N
Synonympyridylpiperazinemonohydrochloride;2-(1-PIPERAZINYL)PYRIDINE MONOHYDROCHLORIDE;1-PYRIDIN-2-YL-PIPERAZINE HYDROCHLORIDE;1-(2-PYRIDYL)PIPERAZINE HYDROCHLORIDE;1-(2-PYRIDYL)PIPERAZINE MONOHYDROCHLORIDE;1-(2-PYRIDYL)PIPERAZINE HCL;1-(2-pyridinyl)piperaizne hydrochioride;1-(2-pyridinyl)piperazinehydrochloride
CAS No.129394-11-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352+P332+P313+P362+P364-P305+P351+P338+P337+P313

Synthetic Route by SureRoute

1. ACROUF948 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFHXR638 route compound structure diagram
    ACFHXR638109-04-6 In Stock
  2. Plus
  3. ACEUMO414 route compound structure diagram
    ACEUMO41459813-05-7
  4. Then
  5. ACROUF948 route product structure diagram
    ACROUF948129394-11-2
Inquiry

2. ACROUF948 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNRFB208 route compound structure diagram
    ACNRFB2086160-65-2 In Stock
  2. Then
  3. ACROUF948 route product structure diagram
    ACROUF948129394-11-2
Inquiry

Comments (0)